Nov 03, 2022
Australian Sickle Cell Disease Market Assessment
Sickle cell disease (SCD) is a group of rare blood disorders that is inherited in an autosomal recessive manner. Our report lays focus on the market for this disease in Australia.
Australian Sickle Cell Disease (SCD) market size was estimated to be $1.1 Mn in 2022 and is projected to reach $2.6 Mn by 2030, exhibiting a CAGR of 11% during the forecast period.
To know more check out our report on: Australian Sickle Cell Disease Market Assessment Analysis